These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4777700)

  • 1. Survival of 125IUDR labeled tumour cells in the blood stream.
    Pitzurra M; Marconi P; Bistoni F; Palumbo R; Corso S
    Boll Ist Sieroter Milan; 1973; 52(4):349-56. PubMed ID: 4777700
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of tumour-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumour-free syngeneic mice. II. Search for a common antigen in some organs and spontaneous mammary carcinomas.
    Rejthar A; Wotke J
    Folia Biol (Krakow); 1973; 21(1):52-7. PubMed ID: 4693119
    [No Abstract]   [Full Text] [Related]  

  • 3. A tumour-associated membrane antigen transiently expressed by normal cells during mitosis.
    Bertini M; Forni G; Comoglio PM
    Clin Exp Immunol; 1974 Sep; 18(1):101-8. PubMed ID: 4468189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen specificity and immunogenic capacity of 3m KCl cell extracts from ascites tumour ATPCplus.
    Marconi P; Bistoni F; Pitzurra M
    Boll Ist Sieroter Milan; 1974; 53(2):377-91. PubMed ID: 4214542
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of parabiosis on tumour growth in tumour bearing animals.
    Postuma HS
    Arch Chir Neerl; 1973; 25(3):269-82. PubMed ID: 4355262
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological analysis of A strain mice bearing the A-10 mammary adenocarcinoma.
    Tax A; Manson LA
    Cancer Res; 1979 May; 39(5):1739-47. PubMed ID: 85488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 8. [Histocompatibility antigens of 2 transplantable reticulum cell tumors TRH 3 and TRBL 3 (induced in BALB/c/Cb/Se and C57BL/Cb/Se mice with ascites mammary carcinoma ATPC+). I. Transplantability tests].
    Maltzeff N
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1975; 35(1):29-41. PubMed ID: 1243772
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological tumor--host relationships in mice].
    Müller M; Welcker ER; Schlotterhoss I; Henker J
    Allerg Asthma (Leipz); 1969; 15(3):157-62. PubMed ID: 4906036
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertonic salt solution of superficial membrane proteins from ATPc+ mouse ascites tumour which retain tumour specific antigenic properties.
    Pitzurra M; Marconi P; Bistoni F
    Boll Ist Sieroter Milan; 1973; 52(4):346-8. PubMed ID: 4130350
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.
    DeLustro F; Haskill JS
    J Natl Cancer Inst; 1980 Jan; 64(1):131-7. PubMed ID: 6928038
    [No Abstract]   [Full Text] [Related]  

  • 12. [Solubilization of antigens from ATPC+ ascitic tumor using hypertonic sodium solution].
    Marconi P; Bistoni F; Pitzurra M
    Boll Soc Ital Biol Sper; 1973 May; 49(10):534-8. PubMed ID: 4132962
    [No Abstract]   [Full Text] [Related]  

  • 13. Splenic alterations during mammary tumorigenesis: diverse effects on different immune parameters.
    Paul RD; Ghaffar A; Sigel MM; Charyulu V; Lopez DM
    Anticancer Res; 1981; 1(2):63-9. PubMed ID: 6214206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of small doses of the tumor specific antigen on further tumor growth].
    Rejthar A; Wotke J
    Cesk Patol; 1974 Nov; 10(4):188-91. PubMed ID: 4142601
    [No Abstract]   [Full Text] [Related]  

  • 15. Changes in lymphoreticular tissues during growth of a murine adenocarcinoma. 3. Plaque-forming cell response in lymph nodes and spleen.
    Rowland GF; Edwards AJ; Hurd CM; Sumner MR
    J Natl Cancer Inst; 1971 Aug; 47(2):321-7. PubMed ID: 4934422
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenocarcinoma associated antigen: enhancement of tumor growth with serum from animals bearing adenocarcinoma.
    Hakin AA
    Surg Forum; 1975; 26():175-7. PubMed ID: 1216104
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunity to a TA3 tumor subline that grows in allogeneic hosts elicited by strain-specific TA3 tumor cells.
    Lippman MM; Venditti JM; Kline I; Elam DL
    Cancer Res; 1973 Apr; 33(4):679-84. PubMed ID: 4696468
    [No Abstract]   [Full Text] [Related]  

  • 19. Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression.
    Fiszman G; Cattaneo V; de la Torre E; Español A; Colombo L; Sacerdote de Lustig E; Sales ME
    Int Immunopharmacol; 2006 Aug; 6(8):1323-30. PubMed ID: 16782546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental evaluation of in situ oncocide for primary tumor therapy: comparison of tumor-specific immunity after complete excision, cryonecrosis and ligation.
    Neel HB; Ketcham AS; Hammond WG
    Laryngoscope; 1973 Mar; 83(3):376-87. PubMed ID: 4690029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.